NOS3 and metabolic dysfunction-associated steatohepatitis: Moreover, statins improve fibrogenesis in NASH by improving endothelial dysfunction with the restoration of liver sinusoidal endothelial cell (LSEC) and hepatic stellate cells (HSC) phenotype and increase endothelial nitric oxide synthase (eNOS) activity [14-16].